Cargando…

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells

Immune checkpoint inhibitors, which target coinhibitory T cell molecules to promote anticancer immune responses, are on the rise to become a new pillar of cancer therapy. However, current immune checkpoint-based therapies are successful only in a subset of patients and acquired resistances pose addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stecher, Carmen, Battin, Claire, Leitner, Judith, Zettl, Markus, Grabmeier-Pfistershammer, Katharina, Höller, Christoph, Zlabinger, Gerhard J., Steinberger, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439058/ https://www.ncbi.nlm.nih.gov/pubmed/28588576 http://dx.doi.org/10.3389/fimmu.2017.00572

Ejemplares similares

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

TIM-3 Does Not Act as a Receptor for Galectin-9
por: Leitner, Judith, et al.
Publicado: (2013)

Not All Immune Checkpoints Are Created Equal
por: De Sousa Linhares, Annika, et al.
Publicado: (2018)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells
por: Leitner, Judith, et al.
Publicado: (2010)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E
por: Battin, Claire, et al.
Publicado: (2022)

Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
por: Battin, Claire, et al.
Publicado: (2023)

Interrogating ligand-receptor interactions using highly sensitive cellular biosensors
por: Funk, Maximilian A., et al.
Publicado: (2023)

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
por: Griss, Johannes, et al.
Publicado: (2019)

CTLA-4 antibody ipilimumab negatively affects CD4(+) T-cell responses in vitro
por: Rosskopf, Sandra, et al.
Publicado: (2019)

A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samples
por: Battin, Claire, et al.
Publicado: (2017)

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
por: Peng, Qi, et al.
Publicado: (2020)

Neuropilin-1 Acts as a Receptor for Complement Split Products
por: Battin, Claire, et al.
Publicado: (2019)

The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals
por: Leitner, Judith, et al.
Publicado: (2011)

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
por: Prokopi, Anastasia, et al.
Publicado: (2021)

A Highly Sensitive Cell-Based TLR Reporter Platform for the Specific Detection of Bacterial TLR Ligands
por: Radakovics, Katharina, et al.
Publicado: (2022)

PD-1 has a unique capacity to inhibit allergen-specific human CD4(+) T cell responses
por: Rosskopf, Sandra, et al.
Publicado: (2018)

Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients
por: Harrison, Nicole, et al.
Publicado: (2020)

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria
por: Grabmeier-Pfistershammer, Katharina, et al.
Publicado: (2019)

Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients
por: Harrison, Nicole, et al.
Publicado: (2020)

Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
por: Harrison, Nicole, et al.
Publicado: (2021)

4‐1BB costimulation promotes bystander activation of human CD8 T cells
por: Reithofer, Manuel, et al.
Publicado: (2020)

Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade
por: Hübbe, Mie Linder, et al.
Publicado: (2020)

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
por: Lipson, Evan J., et al.
Publicado: (2017)

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
por: Ilcus, Cristina, et al.
Publicado: (2017)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
por: Wang, Xin, et al.
Publicado: (2019)

Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness
por: Zierfuss, Bettina, et al.
Publicado: (2022)

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
por: Wang, Ziming, et al.
Publicado: (2018)

PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
por: Tobin, Joshua W. D., et al.
Publicado: (2021)

PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
por: Viramontes, Karla M., et al.
Publicado: (2022)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
por: O’Donnell, Jake S., et al.
Publicado: (2016)

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
por: Ou, Huilin, et al.
Publicado: (2022)

Relapsing Polychondritis following PD-1 Blockade by an Immune Checkpoint Inhibitor
por: Mutoh, Tomoyuki, et al.
Publicado: (2023)

Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells
por: Makowska, Anna, et al.
Publicado: (2019)

Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma
por: GE, WENFEI, et al.
Publicado: (2023)

Immunotherapy of alveolar echinococcosis via PD‐1/PD‐L1 immune checkpoint blockade in mice
por: Wang, Junhua, et al.
Publicado: (2018)

PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2017)

Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma
por: van Gulijk, Mandy, et al.
Publicado: (2022)

Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4(+) T cells from allergic patients
por: Deifl, S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8dmqj65h0j072h7qoj9usdpmfi